Shukun Luo

Title: Shukun Luo - Innovator in Lentiviral Production

Introduction

Shukun Luo is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of virology, particularly in the production of lentiviruses. His innovative methods have the potential to enhance viral particle maturation and production, which is crucial for various applications in gene therapy and vaccine development.

Latest Patents

Shukun Luo holds a patent for a method that significantly increases lentiviral production. This patent describes a process that enhances viral particle maturation and production by inhibiting or preventing Heme Oxygenase 2 (HO-2) from binding to the group-specific antigen (Gag) of viral proteins. By allowing the delivery of viral proteins to plasma membranes without interference from HO-2, the method facilitates replication and maturation. The invention is particularly applicable to the production of lentiviruses from viral proteins where the Matrix domain (MA) of the Gag is myristoylated. He has 1 patent to his name.

Career Highlights

Shukun Luo is affiliated with Columbia University, where he conducts research and develops innovative solutions in the field of virology. His work has garnered attention for its potential impact on the efficiency of viral production processes.

Collaborations

Shukun Luo has collaborated with notable researchers in his field, including Stephen P. Goff and Yiping Zhu. These collaborations have contributed to the advancement of knowledge and techniques in viral production.

Conclusion

Shukun Luo's innovative methods for increasing lentiviral production represent a significant advancement in virology. His contributions are poised to have a lasting impact on the field, particularly in therapeutic applications.